ACASTI PHARMA
Acasti Pharma is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of innovative proprietary active pharmaceutical ingredients (API) for the management of cardiometabolic disorders, from prevention to treatment, through a novel superior approach to lipid regulation.
ACASTI PHARMA
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2002-01-01
Address:
Laval, Quebec, Canada
Country:
Canada
Website Url:
http://www.acastipharma.com
Total Employee:
11+
Status:
Active
Contact:
450-686-4555
Email Addresses:
[email protected]
Total Funding:
54.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-07 | Grace Therapeutics | Grace Therapeutics acquired by Acasti Pharma | 64 M USD |
Official Site Inspections
http://www.acastipharma.com Semrush global rank: 6.91 M Semrush visits lastest month: 701
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Acasti Pharma"
Acasti Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1-450-686-4555 Acasti Pharma is an emerging biopharmaceutical company dedicated to the …See details»
Acasti Pharma Provides Update Following Acquisition of Grace ...
LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and …See details»
Acasti Pharma - Overview, News & Similar companies - ZoomInfo
Jul 9, 2023 Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH Patients STRIVE-ON is a pivotal Phase 3 trial of GTX-104 to …See details»
Acasti Pharma - Craft
Aug 29, 2024 Laval, QC HQ. Canada. 100-545 Promenade Du Centropolis. New York, NY. United States. 405 Lexington Ave. Laval, QC. Canada. 102-3009 Boulevard de la Concorde ESee details»
Acasti Pharma Announces Successful Completion of its Merger …
LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its previously disclosed acquisition …See details»
Acasti Pharma Provides Update Following Acquisition of Grace ...
LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and …See details»
Acasti Pharma Inc. | LinkedIn
Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery technologies have …See details»
Acasti Pharma Provides Business Update for the Second Quarter of …
Nov 10, 2021 Conference call to be held on Wednesday, November 10th at 1:00 p.m. ETLAVAL, Québec, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the …See details»
Acasti Pharma Reports Fiscal Year 2023 Operational Results - PR …
Jun 23, 2023 Our new, highly motivated, and energized organization is entirely focused on achieving critical value inflection milestones in the quarters and years to come." FY 2023 …See details»
Acasti Announces Definitive Agreement to Acquire Grace
May 7, 2021 National Organization for Rare Disorders, Ataxia-Telangiectasia (2015) Hess et al 1990; CDC Morbidity and Mortality Weekly Report (2008) ... www.acastipharma.com. Investor …See details»
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
Jun 22, 2021 Update on Acquisition of Grace Therapeutics and Strategic Plans for CaPre. LAVAL, Québec, June 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the …See details»
Acasti Pharma Reports Fiscal Year 2022 Operational Results
Jun 21, 2022 Company to Host Conference Call Today at 1:00pm ET. LAVAL, Québec, June 21, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST …See details»
Acasti Pharma Announces Successful Completion of its Merger
LAVAL, Québec, Aug. 27, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti”) (NASDAQ: ACST–TSX-V: ACST), announced today the completion of its...See details»
Acasti Pharma Provides Update Following Acquisition of
LAVAL, Québec, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today provided a business update and …See details»
Acasti Pharma Reports Third Quarter 2023 Operational Results
Feb 14, 2023 Company to Host Conference Call Today at 1:00pm ET. LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST …See details»
Acasti Pharma Appoints Healthcare Industry Leader Michael L.
LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announces that it has appointed …See details»
Acasti Announces Third Fiscal Quarter 2024 Financial Results and ...
PRINCETON, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel …See details»
Acasti Pharma Reports First Quarter 2023 Operational Results
Aug 11, 2022 Given certain cost savings and overall efficiencies implemented across the organization, management believes that it now has sufficient capital to fund operations through …See details»
What is Acasti Pharma? Company Culture, Mission, Values
8 rounds of interviews that was over a month and half period. Two company merge to one and was asked by one to take sides. Never been in such a position were the interviewer would …See details»
Acasti Pharma Provides Business Update for the Third Quarter of …
Feb 14, 2022 Provides updates on key milestones: GTX-104 PK study remains on track for results to be reported in the first half of calendar 2022; GTX-102 and GTX-101 progressing on …See details»